Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant vs. Intraoperative vs. Adjuvant Resection Cavity Radiotherapy of Brain Metastases - A Prospective Randomized Explorative Phase II Trial

NCT05871307 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.

NCT NCT05871307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05871307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant vs. Intraoperative vs. Adjuvant Resection Cavity Radiotherapy of Brain Metastases - A Prospective Randomized Explorative Phase II Trial
Lead sponsor
University Hospital Heidelberg
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 1, 2024
Completion date
May 1, 2029
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, radiotherapy